Drug Approval | May 09, 2024
Gland Pharma receives approval for Edaravone Injection
The product is used to treat amyotrophic lateral sclerosis
The product is used to treat amyotrophic lateral sclerosis
The inspection was carried out from January 28 to February 1, 2025
The launch of Chlorpromazine Hydrochloride for Injection is the latest in a series of recent product launches from Piramal Critical Care
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022
Nearly 6,000 patients have been treated with the drug since 2017
Subscribe To Our Newsletter & Stay Updated
